SBC Medical Group Holdings Incorporated Operating Cash Flow
SBC Medical Group Holdings Incorporated (SBC) reported Operating Cash Flow of $31.74 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13
- SBC Medical Group Holdings Incorporated net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $22.51M.
- SBC Medical Group Holdings Incorporated net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $9.23M, a 378.68% increase year-over-year.
- SBC Medical Group Holdings Incorporated net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $51.96M.
- SBC Medical Group Holdings Incorporated net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$20.88M, a 516.73% decline year-over-year.
- SBC Medical Group Holdings Incorporated net cash provided by (used in) operating activities for fiscal 2025 was $24.67M, a 19.85% increase from fiscal 2024.
- SBC Medical Group Holdings Incorporated net cash provided by (used in) operating activities for fiscal 2024 was $20.58M, a 59.38% decline from fiscal 2023.
- SBC Medical Group Holdings Incorporated net cash provided by (used in) operating activities for fiscal 2023 was $50.67M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 4 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 7 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 10 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $22.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $31.74M 10-Q · filed 2026-08-13 | $83.71M derived: sum of 3 quarters · filed 2026-08-13 | $62.82M derived: sum of 4 quarters · filed 2026-08-13 | |||||||
| 2026-03-31 | $9.23M 10-Q · filed 2026-05-14 | $61.20M derived: sum of 2 quarters · filed 2026-05-14 | $40.31M derived: sum of 3 quarters · filed 2026-05-14 | $31.97M derived: sum of 4 quarters · filed 2026-08-13 | |||||||
| 2025-12-31 | $51.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $31.08M derived: sum of 2 quarters · filed 2026-03-27 | $22.74M derived: sum of 3 quarters · filed 2026-08-13 | $24.67M 10-K · filed 2026-03-27 | |||||||
| 2025-09-30 | -$20.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$29.22M derived: sum of 2 quarters · filed 2026-08-13 | -$27.30M 10-Q · filed 2025-11-14 | -$34.60M derived: sum of 4 quarters · filed 2026-08-13 | |||||||
| 2025-06-30 | -$8.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$6.41M 10-Q · filed 2026-08-13 | -$13.71M derived: sum of 3 quarters · filed 2026-08-13 | -$8.70M derived: sum of 4 quarters · filed 2026-08-13 | |||||||
| 2025-03-31 | $1.93M 10-Q · filed 2026-05-14 | -$5.37M derived: sum of 2 quarters · filed 2026-05-14 | -$363.21K derived: sum of 3 quarters · filed 2026-05-14 | $18.83M derived: sum of 4 quarters · filed 2026-05-14 | |||||||
| 2024-12-31 | -$7.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$2.29M derived: sum of 2 quarters · filed 2026-03-27 | $16.90M derived: sum of 3 quarters · filed 2026-03-27 | $20.58M 10-K · filed 2026-03-27 | |||||||
| 2024-09-30 | $5.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $24.20M derived: sum of 2 quarters · filed 2025-11-14 | $27.89M 10-Q · filed 2025-11-14 | $55.80M derived: sum of 4 quarters · filed 2025-11-14 | |||||||
| 2024-06-30 | $19.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $22.87M 10-Q · filed 2025-08-13 | -$895.26K 10-Q · filed 2024-08-16 | $50.79M derived: sum of 3 quarters · filed 2025-08-13 | $74.86M derived: sum of 4 quarters · filed 2025-08-13 | ||||||
| 2024-03-31 | $3.68M 10-Q · filed 2025-05-15 | -$487.45K 10-Q · filed 2024-05-20 | $31.60M derived: sum of 2 quarters · filed 2025-05-15 | $55.67M derived: sum of 3 quarters · filed 2025-05-15 | $54.75M derived: sum of 4 quarters · filed 2025-05-15 | ||||||
| 2023-12-31 | $27.92M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $51.99M derived: sum of 2 quarters · filed 2025-03-28 | $51.06M derived: sum of 3 quarters · filed 2025-03-28 | $50.67M 10-K · filed 2025-03-28 | -$2.13M 10-K · filed 2024-03-19 | ||||||
| 2023-09-30 | $24.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $23.15M derived: sum of 2 quarters · filed 2024-11-13 | $22.75M 10-Q · filed 2024-11-13 | -$1.72M 10-Q · filed 2023-11-14 | |||||||
| 2023-06-30 | -$921.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-16 | -$1.32M 10-Q · filed 2024-08-16 | |||||||||
| 2023-03-31 | -$393.82K 10-Q · filed 2024-05-20 | ||||||||||
| 2022-12-31 | -$462.82K 10-K · filed 2024-03-19 | ||||||||||
| 2022-09-30 | -$368.41K 10-Q · filed 2023-11-14 | ||||||||||
| 2022-06-30 | -$5.76K 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |